[HTML][HTML] The common gene variants of CYP2C19 affect pharmacokinetics and pharmacodynamics in an active metabolite of clopidogrel in healthy subjects
K Umemura, T Furuta, K Kondo - Journal of Thrombosis and …, 2008 - jthjournal.org
… of the active metabolite in healthy subjects including nine poor metabolizers. We also
demonstrated that the pharmacokinetic parameters, AUC and C max of the active metabolite were …
demonstrated that the pharmacokinetic parameters, AUC and C max of the active metabolite were …
Genetic polymorphisms and the impact of a higher clopidogrel dose regimen on active metabolite exposure and antiplatelet response in healthy subjects
T Simon, DL Bhatt, L Bergougnan… - Clinical …, 2011 - Wiley Online Library
… reduced formation of clopidogrel's active metabolite and reduced antiplatelet response as …
was conducted in healthy subjects. A pooled analysis of data from healthy subjects enrolled in …
was conducted in healthy subjects. A pooled analysis of data from healthy subjects enrolled in …
Stereoselective pharmacokinetics of pazinaclone, a new non-benzodiazepine anxiolytic, and its active metabolite in healthy subjects.
Z Hussein, DJ Mulford, BA Bopp… - British journal of clinical …, 1993 - ncbi.nlm.nih.gov
… MI, metabolite in healthy subjects after single and multiple doses of rac-pazinaclone. … healthy
human subjects. Stereoselectivity was found in the intrinsic clearance of the MI, metabolite, …
human subjects. Stereoselectivity was found in the intrinsic clearance of the MI, metabolite, …
A pharmacokinetic study of the active metabolite of nabumetone in young healthy subjects and older arthritis patients
MJ Kendall, MC Chellingsworth, R Jubb… - European journal of …, 1989 - Springer
… during chronic dosing to healthy subjects and the elderly … concentrations of the major
metabolite have been determined … of young healthy volunteers and an elderly group with arthritis. …
metabolite have been determined … of young healthy volunteers and an elderly group with arthritis. …
Pharmacokinetics and pharmacodynamics of oral oxycodone in healthy human subjects: role of circulating active metabolites
B Lalovic, E Kharasch, C Hoffer, L Risler… - Clinical …, 2006 - Wiley Online Library
… and its oxidative and reductive metabolites in 16 healthy subjects. Hatched bars representing
… The mean total recovery of oxycodone and its metabolites for the 16 subjects was 72% ± 19…
… The mean total recovery of oxycodone and its metabolites for the 16 subjects was 72% ± 19…
New metabolic and pharmacokinetic characteristics of thiocolchicoside and its active metabolite in healthy humans
M Trellu, A Filali‐Ansary, D Françon… - Fundamental & …, 2004 - Wiley Online Library
… its active metabolite M1 obtained after administration of a single 8 mg oral dose of TCC to six
healthy subjects… Pharmacokinetic parameters of TCC and of its active metabolite M1 after a …
healthy subjects… Pharmacokinetic parameters of TCC and of its active metabolite M1 after a …
Effect of CYP2B6 genotype on the pharmacokinetics of sibutramine and active metabolites in healthy subjects
JY Chung, SB Jang, YJ Lee, MS Park… - The Journal of Clinical …, 2011 - Wiley Online Library
… of sibutramine and its active metabolites (desmethylsibutramine [M1] and didesmethylsibutramine
[M2]) was evaluated in 57 healthy subjects. Each subject received a single oral dose …
[M2]) was evaluated in 57 healthy subjects. Each subject received a single oral dose …
The pharmacokinetics of oxcarbazepine and its active metabolite 10‐hydroxy‐carbazepine in healthy subjects and in epileptic patients treated with phenobarbitone or …
A Tartara, CA Galimberti, R Manni… - British journal of …, 1993 - Wiley Online Library
… rapid reduction to the active metabolite 10-hydroxy-… of OXC and its active metabolite,
on the otherhand, does not … 10-OH-CZ kinetics in healthy control subjects and in epileptic …
on the otherhand, does not … 10-OH-CZ kinetics in healthy control subjects and in epileptic …
Effect of lopinavir/ritonavir on the pharmacokinetics of selexipag an oral prostacyclin receptor agonist and its active metabolite in healthy subjects
P Kaufmann, S Niglis, S Bruderer… - British Journal of …, 2015 - Wiley Online Library
… Twenty healthy male subjects were recruited in this study and all provided written informed
… selexipag and 1.14 for its metabolite. Subjects were assessed to be healthy on the basis of …
… selexipag and 1.14 for its metabolite. Subjects were assessed to be healthy on the basis of …
Increased active metabolite formation explains the greater platelet inhibition with prasugrel compared to high-dose clopidogrel
CD Payne, YG Li, DS Small… - Journal of …, 2007 - journals.lww.com
… In the current study, prasugrel in healthy subjects produced a more consistent IPA response
than clopidogrel. Several hypotheses have been proposed to account for the interindividual …
than clopidogrel. Several hypotheses have been proposed to account for the interindividual …
相关搜索
- healthy subjects active metabolite of clopidogrel
- healthy subjects active metabolite exposure
- healthy subjects active metabolite of selexipag
- healthy human subjects active metabolites
- active metabolite of nabumetone
- active metabolite formation
- healthy subjects prostacyclin receptor agonist
- healthy subjects antiplatelet response
- healthy subjects pharmacokinetics of sibutramine
- cyp2c19 poor metabolizers active metabolite exposure
- doses in healthy subjects
- active metabolite young healthy subjects
- cyp2c8 inhibitor active metabolite of selexipag
- active metabolite common gene variants
- antiplatelet effects active metabolite exposure
- older arthritis patients young healthy subjects